Global Abortion Drugs Market: Drivers
The abortion drugs market is expected to experience significant growth over the forecast period due to increasing abortion cases among women, globally. For instance, according to the Centers for Disease Control and Prevention, 623,471 abortion cases were reported in 2016. According to the same source, rate of abortion was 11.6 per 1,000 individual women who are in the age group of 15 to 44 years in 2016.
Furthermore, in 2016, new label for mifepristone medicine was approved by the U.S. Food and Drug Administration (FDA). Moreover, the U.S FDA approval of new label for mifepristone assures safety of medicine for all women.
Market Taxonomy:
On the basis of drug, the global abortion drugs market is segmented into:
On the basis of distribution channel, the global abortion drugs market is segmented into:
On the basis of region, the global abortion drugs market is segmented into:
Abortion Drugs Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients